Distillate Capital Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-218,848
Closed -$17.3M 128
2025
Q4
$17.3M Sell
218,848
-3,795
-2% -$298K 0.89% 43
2025
Q3
$17.8M Buy
+222,643
New +$19M 0.92% 37
2022
Q3
Sell
-96,723
Closed -$7.75M 108
2022
Q2
$7.75M Buy
96,723
+19,956
+26% +$1.56M 1.11% 22
2022
Q1
$5.82M Buy
76,767
+12,333
+19% +$977K 0.83% 58
2021
Q4
$5.5M Buy
64,434
+20,771
+48% +$1.62M 0.92% 34
2021
Q3
$3.3M Buy
43,663
+4,795
+12% +$381K 0.88% 49
2021
Q2
$3.16M Buy
38,868
+8,150
+27% +$666K 0.88% 40
2021
Q1
$2.42M Buy
30,718
+8,594
+39% +$674K 0.78% 65
2020
Q4
$1.88M Buy
+22,124
New +$1.83M 0.9% 41

Other funds holding CL

Distillate Capital Partners's CL Position: Q1 2026 in Review

Distillate Capital Partners sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 218,848 shares — an estimated $17.3M sold.

Distillate Capital Partners first reported a position in CL in Q4 2020 and held it in 9 quarters. The position peaked at $17.8M in Q3 2025. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Distillate Capital Partners reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • Distillate Capital Partners sold 218,848 Colgate-Palmolive shares in Q1 2026, an estimated $17.3M.
  • Distillate Capital Partners first reported a position in Colgate-Palmolive in Q4 2020 and held it in 9 quarters.
  • Distillate Capital Partners's Colgate-Palmolive position peaked at $17.8M in Q3 2025.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Distillate Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.